Fischer Medical Ventures Limited has submitted the Exchange a copy Srutinizers report of undefined held on September 29, 2025
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has submitted the Scrutinizer's Report on the voting results of its 32nd Annual General Meeting (AGM) held on September 29, 2025, via video conferencing. The meeting saw a turnout of about 71.5% of total shares, with 463.7 million votes polled out of 648.5 million outstanding shares. All five resolutions — adoption of audited financial statements for FY25, declaration of a 0.5% dividend, re-appointment of Director Mr. Ravindran Govindan, re-appointment of Statutory Auditors M/s Bilimoria Mehta & Co., and appointment of Secretarial Auditors — were passed with over 99.99% votes in favor. The report was issued by Scrutinizer Nuren Lodaya & Associates on September 30, 2025.
Routine procedural filing confirming shareholder approval of standard AGM items including a small 0.5% dividend. No material impact on stock price is expected from this disclosure, but confirms strong shareholder support for the company's governance decisions.